Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

348396

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what proportion of cancer patients received (a) intensity modulated and (b) stereotactic radiotherapy in the latest month for which figures are available.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	952
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England monitors the progress in achieving the following standard:</p><p> </p><p> </p><p> </p><p>- A minimum 24% of patients requiring radical radiotherapy have access to inverse planned Intensity Modulated Radiotherapy (IMRT).</p><p> </p><p> </p><p> </p><p>NHS England monitors this standard as a three month rolling average. The latest data shows that 6,397 patients received IMRT during the period from December 2014 to February 2015, a proportion of 37% of patients requiring radical radiotherapy.</p><p> </p><p> </p><p> </p><p>NHS England does not hold data centrally relating to the proportion of cancer patients receiving stereotactic radiotherapy.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 14:33:38 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

348412

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether NHS England plans to establish reference prices for medical devices beyond those named in the Commissioning Intentions for 2015-16.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	1018
answer	answer is ministerial correction date of answer 10/06/2015 answer text <p>The commissioning intentions state NHS England will look at excluded devices and some drugs. The process began with implantable cardiac devices, bone anchored hearing devices and transcatheter aortic valve implantation, and proceeded to cover all excluded devices.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 10/06/2015 15:53:16 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347775

registered interest
date	01/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Inspections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to ensure that the Care Quality Commission publishes more of its inspection reports on time.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	633
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care providers in England. The CQC is responsible for developing and consulting on its methodology for assessing whether providers are meeting the levels of safety and quality, including the decisions of when to publish inspection reports.</p><p> </p><p><strong> </strong></p><p> </p><p>The CQC has provided the following information:</p><p> </p><p> </p><p> </p><p>The CQC Business Plan for 2015/16 sets out Key Performance Indicators (KPIs) to be used to monitor progress and to improve reporting to its Board and to the public. These KPIs include an aim to publish inspection reports within 50 days of an inspection. This timeframe has been extended to 65 days for hospitals so as to accommodate the extensive nature of the post-inspection process, although this is not included in the Business Plan as it is exclusive to the hospitals directorate.</p><p> </p><p> </p><p> </p><p>Since the introduction of the new approach inspections in 2014, CQC has continued to refine the process around the publication of inspection reports. Processes have been developed to reduce the numbers of checks applied to each report as staff have become more familiar with the new methodology. There has been increased training and support for staff to fully embed the new inspection methodology and extensive inspector recruitment to fill staff vacancies. Reports are also subject to factual accuracy checks and rigorously quality assured prior to publication.</p><p> </p><p> </p><p> </p><p>Other processes put in place by CQC to improve timely publication of reports include:</p><p> </p><p> </p><p> </p><p>- The establishment of quality action groups to address any performance issues.</p><p> </p><p>- Provision of initial feedback to providers at the conclusion of a planned inspection with the initiation of any required enforcement action shortly afterwards. This ensures that any action can be taken by the provider without having to wait for the final report to be published.</p><p> </p><p>- Acceleration in the production of urgent reports for services identified as higher risk straight to National Panel for a final decision prior to publication.</p><p> </p><p> </p><p> </p><p>The quality of the inspection and the report is CQC’s key priority and CQC will continue to refine processes where necessary to ensure continued improvements in the timeliness of the inspection report publication.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 09/06/2015 11:42:19 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347776

registered interest
date	01/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Temporary Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans NHS England has to reduce the cost of agency staff to the NHS in England.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	632
answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England will be writing to clinical commissioning groups clarifying their responsibilities in respect of financial controls for agency spend which are due to be implemented from 1 July as set out in the letter from the Department of Health, a copy of which has been attached.</p><p> </p><p> </p><p> </p><p>The Government is clear that the current rate of spending is not supporting the best positive outcome for patients. The Secretary of State has announced a comprehensive package of measures to address the problem including:</p><p> </p><p>- setting a maximum hourly rate for doctors and nurses;</p><p> </p><p>- banning the use of agencies that are not approved;</p><p> </p><p>- putting a cap on total agency staff spending for each National Health Service trust in financial difficulty; and</p><p> </p><p>- requiring specific approval for any consultancy contracts over £50,000.</p><p> </p><p> </p><p> </p><p>Following the Francis[1] report many trusts increased their spend on temporary staffing to meet safe staffing levels. The Department expects the NHS to have a strong grip on its finances, and manage contract and agency staffing spend responsibly through effective and efficient workforce planning and management.</p><p> </p><br /><p>[1] <a href="http://www.midstaffspublicinquiry.com/" target="_blank">http://www.midstaffspublicinquiry.com</a></p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 09/06/2015 12:20:16 answering member 1201 label Biography information for Alistair Burt attachment 1 file name DH letter of financial responsibilities.pdf title DH letter - finanical controls for agency spend
tabling member	1506 label Biography information for Andrew Gwynne

347367

registered interest
date	28/05/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the process was by which reference prices for implantable defibrillators and cardiac resynchronisation defibrillators were determined.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	349
answer	answer is ministerial correction date of answer 04/06/2015 answer text <p>Trust secondary user service (SUS) data and reference cost submissions for implantable defibrillators and cardiac resynchronisation defibrillators were used to collate draft average reference prices. These were validated and enhanced where appropriate from available procurement frameworks, recent market tenders, a project in the South West and work with a number of lead clinicians.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 04/06/2015 16:52:46 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347368

registered interest
date	28/05/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what categories of implantable defibrillators and cardiac resynchronisation defibrillators have been established for reference price purposes; and what the reference price is for each category.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	350
answer	answer is ministerial correction date of answer 04/06/2015 answer text <p>The reference prices are categorised under the seven categories used by the suppliers of implantable defibrillators and cardiac resynchronisation defibrillators to identify the type of device used. The reference prices are as follows:</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td><p>Summary Description</p></td><td><p>Reference Price<br> excluding VAT</p></td><td><p>NICE Guidelines prices</p></td></tr><tr><td><p>CRT - D Generator</p></td><td><p>£12,500</p></td><td><p> </p></td></tr><tr><td><p>CRT - D System</p></td><td><p>£12,700</p></td><td><p>£12,293</p></td></tr><tr><td><p>Dual Chamber ICD Gen</p></td><td><p>£10,600</p></td><td><p> </p></td></tr><tr><td><p>Dual Chamber ICD Sys</p></td><td><p>£10,800</p></td><td><p>£9,692</p></td></tr><tr><td><p>Single Chamber ICD Gen</p></td><td><p>£9,300</p></td><td><p> </p></td></tr><tr><td><p>Single Chamber ICD Sys</p></td><td><p>£9,450</p></td><td><p> </p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 04/06/2015 16:55:56 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347377

registered interest
date	28/05/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what advice his Department offers trusts on the use of reference prices for implantable defibrillators and cardiac resynchronisation defibrillators.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	382
answer	answer is ministerial correction date of answer 04/06/2015 answer text <p>Reference prices have been issued to commissioners to help them assess value for money on device expenditure and identify potential areas for future efficiency improvements.</p><p> </p><p> </p><p> </p><p>Trusts are obliged to charge the National Health Service the cost of the implantable devices on a pass through basis, i.e. the cost invoiced by the supplier of the device. However, local commissioners will support any trust access to European Union compliant procurement frameworks that offer better value for the taxpayer.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 04/06/2015 16:45:53 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347380

registered interest
date	28/05/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many trusts have contributed the prices they have paid to the calculation of reference prices for implantable defibrillators and cardiac resynchronisation defibrillators; and how many individual device prices were used in that calculation.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	383
answer	answer is ministerial correction date of answer 04/06/2015 answer text <p>In total, 52 providers are commissioned to implant defibrillators and cardiac resynchronisation defibrillators. Secondary User Service data and reference cost submissions from all these trusts were used in calculating the reference price. Available information from 25 provider tenders and procurement frameworks were also used.</p><p> </p><p> </p><p> </p><p>NHS England is also undertaking a project in the South West to better understand the available data on device prices. This has informed the development of an improved minimum dataset which has been introduced in 2015/16. NHS England will continue to work with providers, lead clinicians and the Association of British Healthcare Industries to update their reference price data on an ongoing basis.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 04/06/2015 16:47:33 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

347384

registered interest
date	28/05/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of reference prices for implantable defibrillators and cardiac resynchronisation defibrillators on the ability of trusts to deliver recommendations in NICE Technology Appraisal Guidance 314, published in June 2014.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	404
answer	answer is ministerial correction date of answer 04/06/2015 answer text <p>As reference prices shared with commissioners are between 3% and 11% higher than those stated in the National Institute for Health and Care Excellence (NICE) Technology Appraisal Guidance TA314, NHS England does not anticipate that there will be any adverse impact on the ability of trusts to deliver on NICE recommendations. In other words, because the reference cost is higher, providers are paid more than the NICE guidance costs. However, this will be monitored as part of the routine contract management process through the improved dataset submissions.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 04/06/2015 16:44:15 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

229131

registered interest
date	23/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will recommend to NICE that it updates the EQ5D methodology to better represent meaningful quality of life measures used in assessing cost-effectiveness for interventions that could affect the long-term survival of stroke patients with associated disability.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	228724
answer	answer is ministerial correction date of answer 26/03/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the development of the methods it uses in the development of its guidance. NICE reviews its methods and processes periodically, including consultation with stakeholders, to ensure that they remain appropriate. Ministers are able to refer topics to NICE to be included in their work programme.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 26/03/2015 11:18:38 answering member 4020 label Biography information for George Freeman
tabling member	1506 label Biography information for Andrew Gwynne